Assessment of IMATINIB 400mg as first line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI